| Health Care Technology Industry | Healthcare Sector | Mr. Liu Jun CEO | XSHE Exchange | CNE1000009R5 ISIN |
| CN Country | 9,097 Employees | 28 Feb 2014 Last Dividend | 22 Jun 2016 Last Split | 6 Mar 2008 IPO Date |
New Journey Health Technology Group Co., LTD, previously known as Hengkang Medical Group Co., Ltd., is a comprehensive healthcare company. Since its establishment in 2001, it has committed to the provision of medical services and pharmaceutical products within China and on an international scale. The company administers a network of regional medical centers along with tertiary and second-level hospitals, delivering advanced medical care. Its operations extend beyond clinical services into multiple sectors including research and development, production, sale of pharmaceutical products, Chinese herbal medicine planting, technology consulting, investment management, and even retail and catering services, making it a versatile entity in the healthcare and pharmaceutical industry. Headquartered in Beijing, China, New Journey Health Technology Group Co., LTD embodies a multifaceted approach to healthcare, combining traditional Chinese medicine with modern medical practices.
These are pharmaceutical products designed for specific therapeutic uses, though the text does not specify their exact application. The production and sale of these capsules and tablets represent a key aspect of the company's pharmaceutical branch.
Part of the company's commitment to integrating traditional Chinese medicine into contemporary healthcare solutions, Shenqi Wuweizi tablets are likely formulated from natural herbs, aimed at improving overall health and well-being.
Another product that underscores New Journey Health Technology Group's dedication to offering pharmaceutical solutions derived from herbal medicine. Maiping tablets, like other products, are developed following rigorous research and development protocols to ensure efficacy and safety.
These tablets are targeted at addressing specific health concerns, potentially in the realm of men's health or urinary conditions, judging by the name. The company's pharmaceutical segment ensures the availability of such specialized treatments.
Gongliuning capsules are presumably designed for women's health, given the patterns in traditional Chinese medicine product naming. They exemplify New Journey Health Technology Group's focused approach on gender-specific health issues.
In addition to these pharmaceutical products, New Journey Health Technology Group Co., LTD provides extensive services in Chinese herbal medicine planting, reflecting its root in traditional practices. It also involves in technology research, development, and consulting, ensuring that its practices are backed by the latest scientific findings, along with handling investment management and consulting. Asset, medical project, and industrial investment facets of the company demonstrate its capability in advancing healthcare infrastructure. The diversity extends to drug discovery, which is crucial for expanding its portfolio of health solutions. Moreover, the company ventures into retail, offering its medical and health products directly to consumers, and catering businesses, which may serve to support its healthcare facilities or offer health-oriented food services.